Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 15, 2006 (Vol. 26, No. 20)

GeneWays

URL:geneways.genomecenter.columbia.edu
  • Automation
  • Could be more informative
The expansion of scientific information is occurring at a pace faster than it is being efficiently managed. Consequently, the development of tools for handling and even identifying this data are as important if not more so than the data itself. Toward this end comes GeneWays, a tool that uses natural language processing (NLP) to scan thousands of research articles in order to automatically extract relevant molecular knowledge. Well, they certainly caught my attention, so I read on – “GeneWays' architecture combines various modules designed to automatically gather knowledge on signal transduction pathways from online scientific journals.” The approach has most recently been detailed in Scientific American. Note that the dataset can be downloaded, so the best thing to do with the site is to check it out.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »